3/26/2019 | BKCVDDEMIGPV | Market Commentary: Allison Transmission oversubscribed; Endo, Par Pharma jump; Bed Bath & Beyond surges
|
3/15/2019 | BKCVDDEMIGPV | Market Commentary: Power Solutions carries over; SS&C Technologies, Par in focus; Community Health drops
|
3/14/2019 | BKCVDDEMIGPV | Market Commentary: SS&C Technologies, Endo price; Amkor, Ashton Woods trade up; funds add $1.04 billion
|
11/25/2009 | CV | Par Pharmaceutical holders tender $30.81 million 2.875% convertibles
|
11/9/2009 | CV | Par extends tender offer for 2.875% convertibles, increases price
|
10/14/2009 | CV | Par begins modified Dutch auction tender offer for 2.875% convertibles
|
8/4/2009 | CV | Par Pharmaceutical buys back $49.3 million of its convertible debt
|
6/25/2009 | CVDD | Par Pharmaceutical avoids acceleration of 2.875% convertibles
|
6/19/2009 | CVIG | Par Pharmaceutical files $150 million shelf for stock, debt, warrants
|
11/6/2008 | CV | Par Pharma buys back $58 million of 2.875% convertible notes due 2010
|
10/6/2006 | BTCVDD | Par Pharmaceutical receives acceleration notice on $200 million 2.875% convertibles
|
9/6/2006 | BTCVDD | Par Pharmaceutical receives disputed default notice on 2.875% convertibles
|
8/1/2006 | CV | Market Commentary: Kodak holds against outlook; Scottish Re calms nerves; Itron gains off the blocks; GM declines
|
7/18/2006 | CV | Market Commentary: Avnet improves on Lehman recommendation; Sanmina-SCI unmoved by warning; New River plans deal
|
7/7/2006 | CV | Market Commentary: PMC-Sierra trips on outlook, CFO's resignation; General Motors up on meeting; Par Pharmaceutical eases
|
7/6/2006 | CV | Market Commentary: Par Pharmaceutical gains amid restatements; Openwave slips on weak forecast; tech names better bid
|
5/1/2006 | CV | Market Commentary: Level 3 gains on $1.2 billion acquisition; Teva gets court boost; Human Genome tightens on drug trials
|
3/29/2006 | CV | Market Commentary: Lear gains on financing news, Amdocs strengthens; new issue from AMG fails to enthuse
|
2/28/2006 | CV | Market Commentary: Mentor Graphics up on debut; Citadel down on challenge by bondholders; ArvinMeritor to price new deal
|
12/16/2005 | CV | Market Commentary: OSI Pharmaceuticals new issue rises, but ON Semiconductor slips; Carnival lower on higher dividend fears
|
12/9/2005 | CV | Market Commentary: Cephalon, Teva gain on patent settlement; eyes turn toward Omnicare; Alltel mostly quiet
|
10/27/2005 | CV | Market Commentary: GM bonds lower, credit widens on bankruptcy scare; Digital River plunges; Par Pharma in
|
10/11/2005 | CV | Market Commentary: GM, Ford trade mixed, but remain market focus; Skyworks holds up after lower guidance; Inco rises
|
9/1/2005 | CV | Market Commentary: Airtran, Northwest lead airline convertibles lower; autos sink; Chiron, Phar Pharma gain
|
8/18/2005 | CV | Market Commentary: Six Flags selling on upswing from Snyder's move; Northwest, Delta drift higher, Charming Shoppes up
|
7/28/2005 | CV | Market Commentary: L-3's new convertibles take market focus, Northwest Airlines gains; FTI deal prices after close
|
2/22/2005 | CV | Market Commentary: Level 3 converts rise on private deal; UniSource, Allied Waste deals emerge; Par, Ivax, Teva up
|
11/23/2004 | CV | Market Commentary: Sirius soars on numbers; XM rides wave higher too; Disney easier; Par Pharma trades up
|
7/7/2004 | CV | Market Commentary: Omnicom, AMG spiral on new CoCo rule possibility; EDS active on tighter credit
|